2.4.1.38: beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase
This is an abbreviated version!
For detailed information about beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase, go to the full flat file.
Word Map on EC 2.4.1.38
-
2.4.1.38
-
galts
-
galactosylate
-
synthesis
-
alpha-lactalbumin
-
p34cdc2-related
-
beta4galts
-
drug development
-
pharmacology
-
medicine
- 2.4.1.38
-
galts
-
galactosylate
- synthesis
- alpha-lactalbumin
-
p34cdc2-related
- beta4galts
- drug development
- pharmacology
- medicine
Reaction
Synonyms
(alpha4Gal-T1), 4betaGalT, acetyllactosamine synthetase, alpha-1,4-galactosyltransferase I, B4GALT1, beta 1, 4-GalT-I, beta 1,4-galactosyltransferase 1, beta 1,4-GalT-I, beta 1,4GalT V, beta(1,4)-galactosyltransferase, beta(1,4)-GalT, beta(1,4)-GT, beta-1,4 galactosyltransferase I, beta-1,4 galactosyltransferase V, beta-1,4-galactosyltransferase, beta-1,4-galactosyltransferase 1, beta-1,4-galactosyltransferase I, beta-1,4-galactosyltransferase IV, beta-1,4-galactosyltransferase-I, beta-1,4-GalT, beta-1,4-GalT I, beta-1,4-GalT V, beta-1,4-GalT-I, beta-1,4-GalT5, beta-1,4-GalT6, beta-1,4-GalT7, beta-1,4-GT-IV, beta-N-acetyl-beta1-4-galactosyltransferase, beta-N-acetylglucosaminide beta1-4-galactosyltransferase, beta1,4-Gal-transferase T1, beta1,4-galactosyltransferase, beta1,4-galactosyltransferase 1, beta1,4-galactosyltransferase 7, beta1,4-galactosyltransferase I, beta1,4-galactosyltransferase II, beta1,4-galactosyltransferase V, beta1,4-galactosyltransferase-1, beta1,4-galactosyltransferase-I, beta1,4-galactosyltransferase1, beta1,4-GalT1, beta1,4-GalT7, beta1,4-GT, beta1,4-GT 1, beta1,4GalT II, beta1,4GT1, beta1-4-galactosyltransferase, beta1-4GalT, beta1-4GalT1, beta4 Gal-transferase, beta4-GalT-I, beta4-GalT-II, beta4-GalT-III, beta4-GalT-IV, beta4-GalT-V, beta4Gal-T1, beta4GalT, beta4GalT-II, beta4GalT1, beta4GalT7, betaGalT, betaGalT-1, betaGALT1, betaGT, EC 2.4.1.98, Gal-T, Gal-T1, galactosyltransferase 7, galactosyltransferase, uridine diphosphogalactose-acetylglucosamine, GalNAcT2, GALT, GalT I, GalT V, GalT1, GalTase, GalTI, glycoprotein 4-beta-galactosyl-transferase, glycoprotein beta-galactosyltransferase, HP0826, lactosamine synthase, lactosamine synthetase, lactose synthetase A protein, LgtB, LgtB-A, LgtB-B, LgtH, More, N-acetylglucosamine beta1,4 galactosyltransferase, N-acetyllactosamine synthetase, NAL synthetase, thyroid galactosyltransferase, thyroid glycoprotein beta-galactosyltransferase, UDP-beta-1,4-galactosyltransferase, UDP-Gal:betaGlcNAc beta-1,4-galactosyltransferase, polypeptide 1, UDP-Gal:N-acetylglucosamine beta1-4-galactosyltransferase, UDP-galactose N-acetylglucosamine beta-4-galactosyltransferase, UDP-galactose-acetylglucosamine galactosyltransferase, UDP-galactose-N-acetylglucosamine beta-1,4-galactosyltransferase, UDP-galactose-N-acetylglucosamine galactosyltransferase, UDP-galactose:N-acetylglucosaminide beta1-4-galactosyltransferase, UDP-N-acetylgalactosamine:polypeptide N-acetylgalactosaminyltransferase 2, UDPgalactose-glycoprotein galactosyltransferase, UDPgalactose-N-acetylglucosamine beta-D-galactosyltransferase, UDPgalactose:N-acetyl-beta-D-glucosaminylglycopeptide beta-1,4-galactosyltransferase, UDPgalactose:N-acetylglucosaminyl(beta1-4)galactosyltransferase, uridine diphosphogalactose-acetylglucosamine galactosyltransferase, uridine diphosphogalactose-glycoprotein galactosyltransferase
ECTree
2.4.1.38 beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferaseAdvanced search results
results (
results (Substrates Products
Substrates Products on EC 2.4.1.38 - beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase
Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
top
SUBSTRATE 
PRODUCT
REACTION DIAGRAM
ORGANISM
UNIPROT
COMMENTARY
(Substrate)
(Substrate)
LITERATURE
(Substrate)
(Substrate)
COMMENTARY
(Product)
(Product)
LITERATURE
(Product)
(Product)
Reversibility
r=reversible
ir=irreversible
?=not specified
r=reversible
ir=irreversible
?=not specified
UDP-alpha-D-galactose + 4-methylumbelliferyl beta-D-Glc(1->3)-beta-D-Gal-(1->4)-beta-D-Glc
?
-
95-100% activity
-
-
?
UDP-alpha-D-galactose + 4-methylumbelliferyl beta-D-GlcNAc(1->3)-beta-D-Gal-(1->4)-beta-D-Glc
?
UDP-alpha-D-galactose + 4-methylumbelliferyl beta-D-GlcNAc-(1->3)-beta-D-Gal-(1->4)-beta-D-Glc
?
-
90-95% activity
-
-
?
UDP-alpha-D-galactose + 4-methylumbelliferyl beta-D-GlcNAc-N3(1->3)-beta-D-Gal-(1->4)-beta-D-Glc
?
UDP-alpha-D-galactose + 4-methylumbelliferyl beta-D-GlcNAc6N3(1->3)-beta-D-Gal-(1->4)-beta-D-Glc
?
UDP-alpha-D-galactose + 4-methylumbelliferyl beta-D-GlcNAc6NH2(1->3)-beta-D-Gal-(1->4)-beta-D-Glc
?
-
20% activity
-
-
?
UDP-alpha-D-galactose + 4-methylumbelliferyl beta-D-GlcNAc6OSO3-(1->3)-beta-D-Gal-(1->4)-beta-D-Glc
?
-
100% activity
-
-
?
UDP-alpha-D-galactose + 4-methylumbelliferyl beta-D-GlcNAcPh(1->3)-beta-D-Gal-(1->4)-beta-D-Glc
?
UDP-alpha-D-galactose + 4-methylumbelliferyl beta-D-GlcNAcPhPh(1->3)-beta-D-Gal-(1->4)-beta-D-Glc
?
-
100% activity
-
-
?
UDP-alpha-D-galactose + 4-methylumbelliferyl beta-D-GlcNGc(1->3)-beta-D-Gal-(1->4)-beta-D-Glc
?
UDP-alpha-D-galactose + 4-methylumbelliferyl beta-D-GlcNTFA(1->3)-beta-D-Gal-(1->4)-beta-D-Glc
?
UDP-alpha-D-galactose + 4-methylumbelliferyl beta-D-GlcNTFA-(1->3)-beta-D-Gal-(1->4)-beta-D-Glc
?
-
60-65% activity
-
-
?
UDP-alpha-D-galactose + 4-methylumbelliferyl-beta-D-xylopyranoside
?
-
-
-
?
UDP-alpha-D-galactose + galactosyl-beta-1,4-N-acetylglucosaminyl-beta-1,2-mannosyl-alpha-1,6-(N-acetylglucosaminyl-beta-1,2-mannosyl-alpha-1,3-)mannosyl-beta-1,4-N-acetylglucosaminyl-beta-1,4-(fucosyl-alpha-1,6-)N-acetylglucosaminyl-asparagine
?
-
-
-
-
?
UDP-alpha-D-galactose + N-acetyl-beta-D-glucosaminylglycopeptide
UDP + beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminylglycopeptide
UDP-alpha-D-galactose + N-acetylglucosaminyl-beta-1,2-mannosyl-alpha-1,6-(galactosyl-beta-1,4-N-acetylglucosaminyl-beta-1,2-mannosyl-alpha-1,3-)mannosyl-beta-1,4-N-acetylglucosaminyl-beta-1,4-(fucosyl-alpha-1,6-)N-acetylglucosaminyl-asparagine
?
-
-
-
-
?
UDP-Gal + 4-nitrophenyl 2-acetamido-2-deoxy-4-thio-beta-D-glucopyranoside
UDP + Gal-beta-S-1,4-GlcNAcpNP
-
HP0826 catalyzes the synthesis of the thiodisaccharide Gal-beta-S-1,4-GlcNAcpNP as well as Gal-beta-1,4-Man-pNP with total regio- and stereoselectivity, overview
-
-
?
UDP-Gal + 4-nitrophenyl-2-acetamido-2-deoxy-beta-D-glucopyranoside
UDP + ?
-
-
-
-
?
UDP-galactose + 3-deoxy-3-fluoro-GlcNAcbeta-Bn
UDP + Galbeta(1-4)3-deoxy-3-fluoro-GlcNAcbeta-Bn
-
-
-
-
?
UDP-galactose + 4-nitrophenyl beta-D-xylopyranoside
UDP + beta-D-galactopyranosyl-1,4-xylopyranosyl-1-O-4-nitrophenol
-
-
-
-
?
UDP-galactose + 6-deoxy-GlcNAcbeta-Bn
UDP + Galbeta(1-4)6-deoxy-GlcNAcbeta-Bn
-
low activity
-
-
?
UDP-galactose + 6-thio-GlcNAcbeta-Bn
UDP + Galbeta(1-4)6-thio-GlcNAcbeta-Bn
-
low activity
-
-
?
UDP-galactose + benzyl 2-(acetylamino)-2-deoxy-beta-D-glucopyranoside
UDP + benzyl 2-(acetylamino)-2-deoxy-4-O-beta-D-galactopyranosyl-beta-D-glucopyranoside
UDP-galactose + ginsenoside Rg1
UDP + beta-D-galactosyl-1,4-ginsenoside Rg1
-
-
-
-
?
UDP-galactose + GlcNAcbeta1,2-Manalpha1,3-Manbeta-OR
?
an N-linked biantennary oligosaccharide chain, one antenna is attached to the 3-hydroxyl-(1,2-1,3-arm) group of mannose, which is beta-1,4-linked to an N-linked chitobiose, attached to the aspargine residue of a protein
-
-
?
UDP-galactose + GlcNAcbeta1,2-Manalpha1,6 (GlcNAcbeta1,2-Manalpha1,3)Man
?
-
-
-
?
UDP-galactose + GlcNAcbeta1,2-Manalpha1,6-Manbeta-OR
?
an N-linked biantennary oligosaccharide chain, one antenna is attached to the 3-hydroxyl-(1,2-1,6-arm) group of mannose, which is beta-1,4-linked to an N-linked chitobiose, attached to the aspargine residue of a protein
-
-
?
UDP-galactose + GlcNAcbeta1,4-Manalpha1,3-Manbeta-OR
?
an N-linked biantennary oligosaccharide chain, one antenna is attached to the 3-hydroxyl-(1,4-1,3-arm) group of mannose, which is beta-1,4-linked to an N-linked chitobiose, attached to the aspargine residue of a protein
-
-
?
UDP-galactose + methyl 2-acetamido-2-deoxy-beta-D-glucoside
UDP + beta-D-galactosyl-1,4-beta-1-O-methyl-2-deoxy-2-acetylamido-beta-D-glucopyranoside
-
76% of the activity with N-acetylglucosamine
-
-
?
UDP-galactose + methyl 2-bromo-acetamido-2-deoxy-beta-D-glucoside
UDP + beta-D-galactosyl-1,4-1-O-methyl-2-bromo-acetamido-2-deoxy-beta-D-glucoside
-
75% of the activity with N-acetylglucosamine
-
-
?
UDP-galactose + methyl 2-deoxy-2-benzamido-beta-D-glucoside
UDP + beta-D-galactosyl-1,4-1-O-methyl-2-deoxy-2-benzamido-beta-D-glucoside
-
16% of the activity with N-acetylglucosamine
-
-
?
UDP-galactose + N-4-toluenesulfonyl-GlcN
UDP + Galbeta(1-4)N-4-toluenesulfonyl-GlcN
-
-
-
-
?
UDP-galactose + N-acetyl-beta-D-glucosamine
UDP + beta-D-galactosyl-1,4-N-acetyl-beta-D-glucosamine
-
-
-
?
UDP-galactose + N-acetyl-beta-D-glucosaminyl-1,4-N-acetyl-beta-D-glucosamine
UDP + beta-D-galactosyl-1,4-N-acetyl-beta-D-glucosaminyl-1,4-N-acetyl-beta-D-glucosamine
-
-
-
?
UDP-galactose + N-acetyl-beta-D-glucosaminylglycopeptide
UDP + beta-D-galactosyl-(1-4)-N-acetyl-beta-D-glucosaminylglycopeptide
-
for the binding of GlcNAc in the monosaccharide binding site of beta4Gal-T1, there is a hydrophobic N-acetyl group-binding pocket formed by residues Arg359, Phe360, and Ile363 from the ?-helix region in the closed conformation of the long loop, the sugar donor specificity of beta4Gal-T1 toward galactose is determined by the Tyr residue at position 289 in the binding pocket. The two proteins beta4Gal-T1 and alpha-lactalbukin crystallize together as a complex only in the presence of either donor substrate or acceptor Glc or GlcNAc to form lactose synthase. The specificity of the sugar donor is generally determined by a few residues in the sugar-nucleotide binding pocket. The conformational change in beta4Gal-T1 also creates the binding site for a mammary gland-specific protein, alpha-lactalbumin, which changes the acceptor specificity of the enzyme toward glucose to synthesize lactose during lactation
-
-
?
UDP-galactose + N-acetyl-beta-D-glucosaminylglycopeptide
UDP + beta-D-galactosyl-1,4-N-acetyl-beta-D-glucosaminylglycopeptide
UDP-galactose + N-acetylglucosamine
UDP + beta-D-galactosyl-1,4-N-acetyl-beta-D-glucosamine
-
-
-
-
?
UDP-galactose + N-butyryl-GlcNbeta-Bn
UDP + Galbeta(1-4)N-butyryl-GlcNbeta-Bn
-
-
-
-
?
UDP-galactose + N-methanesulfonyl-GlcN
UDP + Galbeta(1-4)N-methanesulfonyl-GlcN
-
-
-
-
?
UDP-galactose + N-trifluoroacetyl-GlcN
UDP + Galbeta(1-4)N-trifluoroacetyl-GlcN
-
-
-
-
?
UDP-galactose + T-(GlcNAcbeta-1-6[Galbeta1-3]GalNAcalpha1-)TTVTPTPTG
UDP + T-(Galbeta1-4GlcNAcbeta-1-6[Galbeta1-3]GalNAcalpha1-)TTVTPTPTG
-
pH 7.0, 0.5 mM, 40% activity
-
-
?
UDP-galactose + TT-(GlcNAcbeta-1-6[Galbeta1-3]GalNAcalpha1-)TVTP(GGA)TPTG
UDP + TT-(Galbeta1-4GlcNAcbeta-1-6[Galbeta1-3]GalNAcalpha1-)TVTP(GGA)TPTG
-
pH 7.0, 0.5 mM, 25% activity
-
-
?
UDP-galactose + TT-(GlcNAcbeta-1-6[Galbeta1-3]GalNAcalpha1-)TVTPTPTG
UDP + TT-(Galbeta1-4GlcNAcbeta-1-6[Galbeta1-3]GalNAcalpha1-)TVTPTPTG
UDP-galactose + TTTVTP-(GlcNAcbeta-1-6[Galbeta1-3]GalNAcalpha1-)TPTG
UDP + TTTVTP-(Galbeta1-4GlcNAcbeta-1-6[Galbeta1-3]GalNAcalpha1-)TPTG
-
pH 7.0, 0.5 mM, 20% activity
-
-
?
UDP-galactose + TTTVTP-(GlcNAcbeta1-6[Galbeta1-3]GalNAcalpha1-)TG
UDP + TTTVTP-(Galbeta-1-4GlcNAcbeta1-6[Galbeta1-3]GalNAcalpha1-)TG
pH 7.0, 0.2 mM, 2% activity in A549 cells, 14% activity in H292 cells relative to benzyl 2-(acetylamino)-2-deoxy-beta-D-glucopyranoside
-
-
?
UDP-glucose + 4-methylumbelliferyl beta-D-xylopyranoside
UDP + 4-O-beta-D-galactosyl-beta-D-glucose
-
1.5% activity with UDO-glucose compared to UDP-galactose
-
-
?
UDP-glucose + N-acetylglucosamine
UDP + beta-D-glucosyl-1,4-N-acetyl-beta-D-glucosamine
-
reaction with 0.3% efficiency. R228K mutation results in a 15-fold higher glucosyltransferase activity, which is further enhanced by alpha-lactalbumin to nearly 25% of the galactosyltransferase activity of the wild type
-
-
?
UDP-glucuronic acid + 4-methylumbelliferyl beta-D-xylopyranoside
UDP + ?
-
-
-
-
?
UDP-N-acetyl-alpha-D-glucosamine + 4-methylumbelliferyl beta-D-xylopyranoside
?
-
-
-
-
?
UDP-N-acetyl-alpha-D-glucosamine + 4-methylumbelliferyl beta-D-xylopyranoside
UDP + ?
-
-
-
-
?
UDPgalactose + 2-acetamido-N-(L-aspart-4-oyl)-1,2-dideoxy-beta-glucoside
?
-
65% of the activity with N-acetylglucosamine
-
-
?
UDPgalactose + agalacto-ovomucoid
?
-
65% of the activity with N-acetylglucosamine
-
-
?
UDPgalactose + agalactokeratan
?
-
agalactokeratan from bovine cornea and nasal septum, at 5% and 13% of the activity with N-acetylglucosamine
-
-
?
UDPgalactose + asialo-agalacto-alpha1-glycoprotein
?
-
42% of the activity with N-acetylglucosamine
-
-
?
UDPgalactose + asialo-agalacto-transferrin
?
-
transfer of galactose to N-acetylglucosamine residues of Asn-linked sugar chains of glycoproteins in a beta1-4linkage
-
-
?
UDPgalactose + degalactosylated fetuin
UDP + fetuin containing beta-1,4-galactose linkages
UDPgalactose + di-acetylchitobiose
?
-
54% of the activity with N-acetylglucosamine
-
-
?
UDPgalactose + GlcNAcbeta-S-p-NP
UDP + Galbeta1-4 GlcNAcbeta-S-p-NP
-
-
-
?
UDPgalactose + GlcNAcbeta1-6(GlcNAcbeta1-2)Manalpha1-3Manbeta1-O(CH2)8COOCH2-mNP
UDP + Galbeta1-4 GlcNAcbeta1-6(GlcNAcbeta1-2)Manalpha1-3Manbeta1-O(CH2)8COOCH2-mNP
-
-
-
?
UDPgalactose + N-acetyl-beta-D-glucosaminyl-glycopeptide
UDP + beta-D-galactosyl-1,4-N-acetyl-beta-D-glucosaminylglycopeptide
UDPgalactose + N-acetylglucosaminyl at the non-reducing ends of protein-bound oligosaccharides
?
UDPgalactose + N-acetylglucosaminyl-beta-1,2-mannosyl-alpha-1,6-(N-acetylglucosaminyl-beta-1,2-mannosyl-alpha-1,3-)mannosyl-beta-1,4-N-acetylglucosaminyl-beta-1,4-(fucosyl-alpha-1,6-)N-acetylglucosaminyl-asparagine
UDP + galactosyl-beta-1,4-N-acetylglucosaminyl-beta-1,2-mannosyl-alpha-1,6-(galactosyl-beta-1,4-N-acetylglucosaminyl-beta-1,2-mannosyl-alpha-1,3-)mannosyl-beta-1,4-N-acetylglucosaminyl-beta-1,4-(fucosyl-alpha-1,6-)N-acetylglucosaminyl-asparagine
-
-
galactose is transferred much faster to the N-acetylglucosaminyl-beta-1,2-mannosyl-alpha-1,3-branch than to the N-acetylglucosaminyl-beta-1,2-mannosyl-alpha-1,6-branch
?
UDPgalactose + N-acetylglucosaminyl-beta-1,3-(galactosyl-beta-1,4-N-acetylglucosaminyl-beta-1,6-)galactose
UDP + galactosyl-beta-1,4-N-acetylglucosaminyl-beta-1,3-(galactosyl-beta-1,4-N-acetylglucosaminyl-beta-1,6-)galactose
-
-
-
-
?
UDPgalactose + N-acetylglucosaminyl-beta-1,3-(N-acetylglucosaminyl-beta-1,6-)galactose
UDP + galactosyl-beta-1,4-N-acetylglucosaminyl-beta-1,3-(N-acetylglucosaminyl-beta-1,6-)galactose
-
-
-
-
?
UDPgalactose + N-acetylglucosaminyl-beta-1,3-galactose
UDP + galactosyl-beta-1,4-N-acetylglucosaminyl-beta-1,3-galactose
-
-
-
-
?
UDPgalactose + N-acetylglucosaminyl-beta-1,6-galactose
UDP + galactosyl-beta-1,4-N-acetylglucosaminyl-beta-1,6-galactose
-
-
-
-
?
UDPgalactose + ovomucoid
UDP + ovomucoid with beta-1,4-bound galactose
-
-
-
?
UDPgalactose + tri-N-acetylchitotriose
?
-
64% of the activity with N-acetylglucosamine
-
-
?
UDP-alpha-D-galactose + 4-methylumbelliferyl beta-D-GlcNAc(1->3)-beta-D-Gal-(1->4)-beta-D-Glc
?
-
100% activity
-
-
?
UDP-alpha-D-galactose + 4-methylumbelliferyl beta-D-GlcNAc(1->3)-beta-D-Gal-(1->4)-beta-D-Glc
?
-
100% activity
-
-
?
UDP-alpha-D-galactose + 4-methylumbelliferyl beta-D-GlcNAc-N3(1->3)-beta-D-Gal-(1->4)-beta-D-Glc
?
-
35-40% activity
-
-
?
UDP-alpha-D-galactose + 4-methylumbelliferyl beta-D-GlcNAc-N3(1->3)-beta-D-Gal-(1->4)-beta-D-Glc
?
-
100% activity
-
-
?
UDP-alpha-D-galactose + 4-methylumbelliferyl beta-D-GlcNAc-N3(1->3)-beta-D-Gal-(1->4)-beta-D-Glc
?
-
100% activity
-
-
?
UDP-alpha-D-galactose + 4-methylumbelliferyl beta-D-GlcNAc6N3(1->3)-beta-D-Gal-(1->4)-beta-D-Glc
?
-
100% activity
-
-
?
UDP-alpha-D-galactose + 4-methylumbelliferyl beta-D-GlcNAc6N3(1->3)-beta-D-Gal-(1->4)-beta-D-Glc
?
-
5-10% activity
-
-
?
UDP-alpha-D-galactose + 4-methylumbelliferyl beta-D-GlcNAcPh(1->3)-beta-D-Gal-(1->4)-beta-D-Glc
?
-
20-25% activity
-
-
?
UDP-alpha-D-galactose + 4-methylumbelliferyl beta-D-GlcNAcPh(1->3)-beta-D-Gal-(1->4)-beta-D-Glc
?
-
50% activity
-
-
?
UDP-alpha-D-galactose + 4-methylumbelliferyl beta-D-GlcNAcPh(1->3)-beta-D-Gal-(1->4)-beta-D-Glc
?
-
100% activity
-
-
?
UDP-alpha-D-galactose + 4-methylumbelliferyl beta-D-GlcNGc(1->3)-beta-D-Gal-(1->4)-beta-D-Glc
?
-
75-80% activity
-
-
?
UDP-alpha-D-galactose + 4-methylumbelliferyl beta-D-GlcNGc(1->3)-beta-D-Gal-(1->4)-beta-D-Glc
?
-
90-95% activity
-
-
?
UDP-alpha-D-galactose + 4-methylumbelliferyl beta-D-GlcNTFA(1->3)-beta-D-Gal-(1->4)-beta-D-Glc
?
-
100% activity
-
-
?
UDP-alpha-D-galactose + 4-methylumbelliferyl beta-D-GlcNTFA(1->3)-beta-D-Gal-(1->4)-beta-D-Glc
?
-
95-100% activity
-
-
?
UDP-alpha-D-galactose + Glc-ITag
UDP + Lac-ITag
Glc-ITag is 3-(4-(3-methylimidazolium)methylbenzyloxycarbonylamino)propyl-beta-D-glucopyranoside
-
-
?
UDP-alpha-D-galactose + Glc-ITag
UDP + Lac-ITag
Glc-ITag is 3-(4-(3-methylimidazolium)methylbenzyloxycarbonylamino)propyl-beta-D-glucopyranoside
-
-
?
UDP-alpha-D-galactose + Glc-ITag
UDP + Lac-ITag
Neisseria meningitidis serogroup A Z2491
Glc-ITag is 3-(4-(3-methylimidazolium)methylbenzyloxycarbonylamino)propyl-beta-D-glucopyranoside
-
-
?
UDP-alpha-D-galactose + Glc-ITag
UDP + Lac-ITag
Glc-ITag is 3-(4-(3-methylimidazolium)methylbenzyloxycarbonylamino)propyl-beta-D-glucopyranoside
-
-
?
UDP-alpha-D-galactose + Glc-ITag
UDP + Lac-ITag
Glc-ITag is 3-(4-(3-methylimidazolium)methylbenzyloxycarbonylamino)propyl-beta-D-glucopyranoside
-
-
?
UDP-alpha-D-galactose + GlcNac-ITag
UDP + LacNAc-ITag
GlcNac-ITag is 3-(4-(3-methylimidazolium)methylbenzylcarbamate)propyl 2-acetamido-2-deoxy-beta-D-glucopyranoside
-
-
?
UDP-alpha-D-galactose + GlcNac-ITag
UDP + LacNAc-ITag
GlcNac-ITag is 3-(4-(3-methylimidazolium)methylbenzylcarbamate)propyl 2-acetamido-2-deoxy-beta-D-glucopyranoside
-
-
?
UDP-alpha-D-galactose + GlcNac-ITag
UDP + LacNAc-ITag
Neisseria meningitidis serogroup A Z2491
GlcNac-ITag is 3-(4-(3-methylimidazolium)methylbenzylcarbamate)propyl 2-acetamido-2-deoxy-beta-D-glucopyranoside
-
-
?
UDP-alpha-D-galactose + GlcNac-ITag
UDP + LacNAc-ITag
GlcNac-ITag is 3-(4-(3-methylimidazolium)methylbenzylcarbamate)propyl 2-acetamido-2-deoxy-beta-D-glucopyranoside
-
-
?
UDP-alpha-D-galactose + GlcNac-ITag
UDP + LacNAc-ITag
GlcNac-ITag is 3-(4-(3-methylimidazolium)methylbenzylcarbamate)propyl 2-acetamido-2-deoxy-beta-D-glucopyranoside
-
-
?
UDP-alpha-D-galactose + N-acetyl-beta-D-glucosaminylglycopeptide
UDP + beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminylglycopeptide
-
-
-
-
?
UDP-alpha-D-galactose + N-acetyl-beta-D-glucosaminylglycopeptide
UDP + beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminylglycopeptide
-
-
-
?
UDP-alpha-D-galactose + N-acetyl-beta-D-glucosaminylglycopeptide
UDP + beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminylglycopeptide
-
-
-
?
UDP-alpha-D-galactose + N-acetyl-beta-D-glucosaminylglycopeptide
UDP + beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminylglycopeptide
-
-
-
?
UDP-alpha-D-galactose + N-acetyl-beta-D-glucosaminylglycopeptide
UDP + beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminylglycopeptide
-
-
-
-
?
UDP-alpha-D-galactose + N-acetyl-beta-D-glucosaminylglycopeptide
UDP + beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminylglycopeptide
-
-
-
-
?
UDP-alpha-D-galactose + N-acetyl-beta-D-glucosaminylglycopeptide
UDP + beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminylglycopeptide
-
-
-
?
UDP-alpha-D-galactose + N-acetyl-beta-D-glucosaminylglycopeptide
UDP + beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminylglycopeptide
-
-
-
?
UDP-alpha-D-galactose + N-acetyl-beta-D-glucosaminylglycopeptide
UDP + beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminylglycopeptide
-
-
-
-
?
UDP-alpha-D-galactose + N-acetyl-beta-D-glucosaminylglycopeptide
UDP + beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminylglycopeptide
-
-
-
-
?
UDP-alpha-D-galactose + N-acetyl-beta-D-glucosaminylglycopeptide
UDP + beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminylglycopeptide
-
-
-
?
UDP-alpha-D-galactose + N-acetyl-beta-D-glucosaminylglycopeptide
UDP + beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminylglycopeptide
-
-
-
?
UDP-alpha-D-galactose + N-acetyl-beta-D-glucosaminylglycopeptide
UDP + beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminylglycopeptide
Neisseria meningitidis serogroup A Z2491
-
-
-
?
UDP-alpha-D-galactose + N-acetyl-beta-D-glucosaminylglycopeptide
UDP + beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminylglycopeptide
-
-
-
?
UDP-alpha-D-galactose + N-acetyl-beta-D-glucosaminylglycopeptide
UDP + beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminylglycopeptide
-
-
-
?
UDP-Gal + 4-nitrophenyl beta-D-mannopyranoside
UDP + Gal-beta-1,4-Man-pNP
-
HP0826 catalyzes the synthesis of the thiodisaccharide Gal-beta-S-1,4-GlcNAcpNP as well as Gal-beta-1,4-Man-pNP with total regio- and stereoselectivity, overview
-
-
?
UDP-Gal + 4-nitrophenyl beta-D-mannopyranoside
UDP + Gal-beta-1,4-Man-pNP
-
LgtB catalyzes the synthesis of Gal-beta-1,4-Man-pNP, overview
-
-
?
UDP-galactose + benzyl 2-(acetylamino)-2-deoxy-beta-D-glucopyranoside
UDP + benzyl 2-(acetylamino)-2-deoxy-4-O-beta-D-galactopyranosyl-beta-D-glucopyranoside
-
pH 7.0, 0.5 mM, 100% activity
-
-
?
UDP-galactose + benzyl 2-(acetylamino)-2-deoxy-beta-D-glucopyranoside
UDP + benzyl 2-(acetylamino)-2-deoxy-4-O-beta-D-galactopyranosyl-beta-D-glucopyranoside
pH 7.0
-
-
?
UDP-galactose + N-acetyl-beta-D-glucosaminylglycopeptide
UDP + beta-D-galactosyl-1,4-N-acetyl-beta-D-glucosaminylglycopeptide
-
-
-
-
?
UDP-galactose + N-acetyl-beta-D-glucosaminylglycopeptide
UDP + beta-D-galactosyl-1,4-N-acetyl-beta-D-glucosaminylglycopeptide
-
catalytic cycle: Mn2+ binds first before UDP-Gal, two flexible loops, a long and a short loop, change their conformation from open to closed
-
-
?
UDP-galactose + N-acetyl-beta-D-glucosaminylglycopeptide
UDP + beta-D-galactosyl-1,4-N-acetyl-beta-D-glucosaminylglycopeptide
-
-
-
?
UDP-galactose + N-acetyl-beta-D-glucosaminylglycopeptide
UDP + beta-D-galactosyl-1,4-N-acetyl-beta-D-glucosaminylglycopeptide
-
-
-
-
?
UDP-galactose + N-acetyl-beta-D-glucosaminylglycopeptide
UDP + beta-D-galactosyl-1,4-N-acetyl-beta-D-glucosaminylglycopeptide
-
-
-
-
?
UDP-galactose + N-acetyl-beta-D-glucosaminylglycopeptide
UDP + beta-D-galactosyl-1,4-N-acetyl-beta-D-glucosaminylglycopeptide
-
-
-
?
UDP-galactose + N-acetyl-beta-D-glucosaminylglycopeptide
UDP + beta-D-galactosyl-1,4-N-acetyl-beta-D-glucosaminylglycopeptide
-
the enzyme effectively galactosylates the GlcNAcbeta1,6Man arm of the highly branched N-glycans that are characteristic of glioma, overview
-
-
?
UDP-galactose + N-acetyl-beta-D-glucosaminylglycopeptide
UDP + beta-D-galactosyl-1,4-N-acetyl-beta-D-glucosaminylglycopeptide
the enzyme transfers galactose from UDP-galactose to N-acetylglucosamine residues of the branched N-linked oligosaccharide chains of glycoproteins
-
-
?
UDP-galactose + N-acetyl-beta-D-glucosaminylglycopeptide
UDP + beta-D-galactosyl-1,4-N-acetyl-beta-D-glucosaminylglycopeptide
-
catalytic cycle: Mn2+ binds first before UDP-Gal, two flexible loops, a long and a short loop, change their conformation from open to closed
-
-
?
UDP-galactose + N-acetyl-beta-D-glucosaminylglycopeptide
UDP + beta-D-galactosyl-1,4-N-acetyl-beta-D-glucosaminylglycopeptide
-
residue Y285 alone is responsible for determination of enzyme substrate specificity, overview, active site structure, overview
-
-
?
UDP-galactose + N-acetyl-beta-D-glucosaminylglycopeptide
UDP + beta-D-galactosyl-1,4-N-acetyl-beta-D-glucosaminylglycopeptide
-
UDP-Gal-Mn2+ substrate binding structure, overview
-
-
?
UDP-galactose + N-acetyl-beta-D-glucosaminylglycopeptide
UDP + beta-D-galactosyl-1,4-N-acetyl-beta-D-glucosaminylglycopeptide
-
100% activity with UDP-galactose
-
-
?
UDP-galactose + p-nitrophenyl-beta-D-N-acetylglucosaminide
?
-
-
-
?
UDP-galactose + p-nitrophenyl-beta-D-N-acetylglucosaminide
?
-
-
-
?
UDP-galactose + TT-(GlcNAcbeta-1-6[Galbeta1-3]GalNAcalpha1-)TVTPTPTG
UDP + TT-(Galbeta1-4GlcNAcbeta-1-6[Galbeta1-3]GalNAcalpha1-)TVTPTPTG
-
pH 7.0, 0.5 mM, 30% activity
-
-
?
UDP-galactose + TT-(GlcNAcbeta-1-6[Galbeta1-3]GalNAcalpha1-)TVTPTPTG
UDP + TT-(Galbeta1-4GlcNAcbeta-1-6[Galbeta1-3]GalNAcalpha1-)TVTPTPTG
-
pH 7.0, 0.5 mM, 35% activity
-
-
?
UDP-GalNAc + GlcNAc
?
-
transfer of GalNAc is only 1% of galactose transfer in wild type enzyme. Mutant enzyme Y289L exhibits nearly 100% of the galactose transferase activity
-
-
?
UDPgalactose + degalactosylated fetuin
UDP + fetuin containing beta-1,4-galactose linkages
-
-
-
?
UDPgalactose + degalactosylated fetuin
UDP + fetuin containing beta-1,4-galactose linkages
-
-
-
-
?
UDPgalactose + degalactosylated fetuin
UDP + fetuin containing beta-1,4-galactose linkages
-
-
-
-
?
UDPgalactose + degalactosylated fetuin
UDP + fetuin containing beta-1,4-galactose linkages
-
-
-
-
?
UDPgalactose + glucose
lactose + UDP
-
in presence of alpha-lactalbumin
-
?
UDPgalactose + glucose
lactose + UDP
-
in presence of alpha-lactalbumin
-
?
UDPgalactose + glucose
lactose + UDP
-
in presence of alpha-lactalbumin
-
-
?
UDPgalactose + glucose
lactose + UDP
-
in presence of alpha-lactalbumin
-
?
UDPgalactose + glucose
lactose + UDP
-
in presence of alpha-lactalbumin
-
?
UDPgalactose + glucose
lactose + UDP
enzyme has no lactose synthase activity in presence of alpha-lactalbumin
-
-
?
UDPgalactose + glucose
lactose + UDP
-
in presence of alpha-lactalbumin
-
?
UDPgalactose + glucose
lactose + UDP
-
in presence of alpha-lactalbumin
-
?
UDPgalactose + glucose
lactose + UDP
-
in presence of alpha-lactalbumin
-
?
UDPgalactose + glucose
lactose + UDP
-
in presence of alpha-lactalbumin
-
?
UDPgalactose + glucose
lactose + UDP
-
in presence of alpha-lactalbumin
-
?
UDPgalactose + glucose
lactose + UDP
-
in presence of alpha-lactalbumin
-
?
UDPgalactose + N-acetyl-beta-D-glucosaminyl-glycopeptide
UDP + beta-D-galactosyl-1,4-N-acetyl-beta-D-glucosaminylglycopeptide
-
glycoproteins containing terminal nonreducing N-acetylglucosaminyl units
-
-
?
UDPgalactose + N-acetyl-beta-D-glucosaminyl-glycopeptide
UDP + beta-D-galactosyl-1,4-N-acetyl-beta-D-glucosaminylglycopeptide
-
glycopeptide prepared from porcine IgG immunoglobulin
-
-
?
UDPgalactose + N-acetylglucosamine
UDP + N-acetyllactosamine
-
-
-
-
?
UDPgalactose + N-acetylglucosamine
UDP + N-acetyllactosamine
-
-
-
-
?
UDPgalactose + N-acetylglucosamine
UDP + N-acetyllactosamine
7% of the activity with GlcNAcbeta-S-pNP
-
-
?
UDPgalactose + N-acetylglucosamine
UDP + N-acetyllactosamine
-
-
-
-
?
UDPgalactose + N-acetylglucosamine
UDP + N-acetyllactosamine
-
-
-
-
?
UDPgalactose + N-acetylglucosamine
UDP + N-acetyllactosamine
-
-
-
?
UDPgalactose + N-acetylglucosamine
UDP + N-acetyllactosamine
-
-
-
-
?
UDPgalactose + N-acetylglucosaminyl at the non-reducing ends of protein-bound oligosaccharides
?
-
-
-
-
?
UDPgalactose + N-acetylglucosaminyl at the non-reducing ends of protein-bound oligosaccharides
?
-
the enzyme facilitates sperm binding to the oocyte zona pellucida
-
-
?
UDPgalactose + N-acetylglucosaminyl at the non-reducing ends of protein-bound oligosaccharides
?
-
enzyme participates in the biosynthesis of the oligosaccharide structures of glycoproteins and glycolipids
-
-
?
UDPgalactose + N-acetylglucosaminyl at the non-reducing ends of protein-bound oligosaccharides
?
-
enzyme functions in the coordinate biosynthesis of complex oligosaccharides, proposed to function in intercellular recognition and/or adhesion
-
-
?
UDPgalactose + N-acetylglucosaminyl at the non-reducing ends of protein-bound oligosaccharides
?
-
biosynthesis of keratan sulfate-like polysaccharides
-
-
?
UDPgalactose + N-acetylglucosaminyl at the non-reducing ends of protein-bound oligosaccharides
?
-
the enzyme may be involved in the synthesis of poly-N-acetyllactosamine, lacto-N-neotetraose and probably lacto-N-neotetraosylceramide in addition to the formation of the Galbeta1-4GlcNAc group of glycoprotein sugar chains and lactose
-
-
?
UDPgalactose + N-acetylglucosaminyl at the non-reducing ends of protein-bound oligosaccharides
?
-
main enzyme responsible for the transfer of galactose residues from UDPgalactose into terminal N-acetylglucosamine residues of complex-type oligosaccharides in newly synthesized glycoproteins in the Golgi apparatus. Deficiency of UDP-galactose:N-acetylglucosamine beta-1,4-galactosyltransferase I causes the congenital disorder of glycosylation type IId, a severe neurologic disease characterized by a hydrocephalus, myopathy and blood-clotting defects
-
-
?
UDPgalactose + N-acetylglucosaminyl at the non-reducing ends of protein-bound oligosaccharides
?
-
the enzyme is involved in the biosynthesis of a variety of carbohydrate structures in glycoproteins and glycolipids
-
-
?
UDPgalactose + N-acetylglucosaminyl at the non-reducing ends of protein-bound oligosaccharides
?
-
biosynthesis of carbohydrate moieties of glycoproteins and glycolipids, role in intercellular recognition and adhesion
-
-
?
UDPgalactose + N-acetylglucosaminyl at the non-reducing ends of protein-bound oligosaccharides
?
-
-
-
-
?
UDPgalactose + N-acetylglucosaminyl at the non-reducing ends of protein-bound oligosaccharides
?
-
the soluble enzyme form from the luminal fluid of the epididymis is suggested to play a role on sperm maturation
-
-
?
UDPgalactose + N-acetylglucosaminyl at the non-reducing ends of protein-bound oligosaccharides
?
-
the enzyme may be involved in the synthesis of plasma glycoproteins by the liver during secretion, and may possibly be required for secretion of these proteins
-
-
?
UDPgalactose + p-nitrophenyl 2-acetamido-2-deoxy-beta-glucoside
?
-
67% of the activity with N-acetylglucosamine
-
-
?
additional information
?
-
-
regioselectivity towards specific C(4)glucose OH group in the complex protopanaxadiol glycoside ginsenoside Rb1
-
-
?
additional information
?
-
-
enzyme also catalyzes unusual galactosyl transfer to the 3-OH position of L-sugars
-
-
?
additional information
?
-
-
enzyme also catalyzes transfer of glucose from UDPglucose to N-acetylglucosamine
-
-
?
additional information
?
-
-
substrate specificity in presence or absence of alpha-lactalbumin, overview, the 'specifier' protein alpha-lactalbumin, which interacts with beta-1,4-GalT forming the lactose synthase complex, EC 2.4.1.2 and changing the substrate specificity to the reaction of EC 2.4.1.90, alpha-lactalbumin is not necessary when the acceptors are different glucopyranosides and, in some cases, it can even have an inhibitory effect, e.g. in reaction with the complex glucosides ginsenoside Rg1 and colchicoside, overview, in absence of alpha-lactalbumin, the enzyme is not active with glucose as acceptor
-
-
?
additional information
?
-
-
the enzyme catalyzes the transfer of Gal from UDP-Gal to GlcNAc-terminating acceptors with inversion of configuration of the glycosidic linkage, in presence of beta-lactalbumin, the enzyme changes its specificity to become lactose synthase, EC 2.4.1.22, and transfers Gal to glucose to synthesize lactose, substrate specificity, e.g. with GlcNAc-terminating O-glycopeptides, no activity with N-trimethylacetyl-GlcN, N,N-dimethyl-GlcN, N-isopropyl-GlcN, and N-(4-MeOBn)GlcN, overview
-
-
?
additional information
?
-
-
no activity with Glcbeta(1->3)Lacbeta-MU, GlcNAc6Sbeta(1->3)Lacbeta-MU, GlcNAc6N3beta(1->3)Lacbeta-MU, GlcNAc6NH2beta(1->3)Lacbeta-MU, GlcNAcPhPhbeta(1->3)Lacbeta-MU, GlcNGcbeta(1->3)Lacbeta-MU, GlcNH2beta(1->3)Lacbeta-MU, GalNAcbeta(1->3)Lacbeta-MU or Galbeta(1->)3Lacbeta-MU as acceptor
-
-
-
additional information
?
-
the enzyme is part of the endoplasmic reticulum and Golgi glycosylation network, glycosyltransferase metabolism, overview
-
-
?
additional information
?
-
-
an enzyme orthologue involved in the synthesis of glycoproteins and glycolipids, the sugar donor specificity of the enzyme toward galactose is determined by the Ile residue at position 289 in the binding pocket. The two proteins beta4Gal-T1 and alpha-lactalbukin crystallize together as a complex only in the presence of either donor substrate or acceptor Glc or GlcNAc to form lactose synthase. The specificity of the sugar donor is generally determined by a few residues in the sugar-nucleotide binding pocket. The conformational change in beta4Gal-T1 also creates the binding site for a mammary gland-specific protein, alpha-lactalbumin, which changes the acceptor specificity of the enzyme toward glucose to synthesize lactose during lactation
-
-
?
additional information
?
-
-
HP0826 is the beta-1,4-galactosyltransferase involved in the biosynthesis of the lipopolysaccharide O-chain backbone of Helicobacter pylori
-
-
?
additional information
?
-
-
HP0826 exhibits a pronounced acceptor promiscuity with the most striking result being the successful transfer of Gal to the 4-SH of pNP-4-S-beta-GlcNAc
-
-
?
additional information
?
-
-
no activity with Glcbeta(1->3)Lacbeta-MU, GlcNAcPhPhbeta(1->3)Lacbeta-MU, GlcNH2beta(1->3)Lacbeta-MU, GalNAcbeta(1->3)Lacbeta-MU or Galbeta(1->)3Lacbeta-MU as acceptor
-
-
-
additional information
?
-
-
enzyme activity might be involved in apoptotic pathway in hepatocarcinoma cells
-
-
?
additional information
?
-
-
decreasing the expression of GalT V in glioma cells promotes apoptosis, inhibits the invasion and migration and the ability of tumor formation in vivo, and reduces the activation of AKT, the enzyme functions as a glioma growth activator, overview, contribution of GalT V in the activation of AKT and MAPK kinase, contribution of serum or EGF in the transcription regulation of the GalT V gene, overview
-
-
?
additional information
?
-
-
downregulation of the enzyme inhibits CDK11(p58)-mediated apoptosis induced by cycloheximide, while ectopically expressed beta1,4-GT 1 increases CDK11p58-mediated apoptosis
-
-
?
additional information
?
-
-
the cell surface enzyme promotes apoptosis by inhibiting the epidermal growth factor receptor pathway via inhibition of the autophosphorylation of epidermal growth factor receptor especially at Try 1068, mechanism, overview
-
-
?
additional information
?
-
-
tumor beta-1,4-galactosyltransferase IV overexpression is closely associated with colorectal cancer metastasis and poor prognosis, relationships between tumor beta-1,4-GT-IV overexpression and clinicopathologic characteristics, overview
-
-
?
additional information
?
-
-
beta-1,4-GTs are a family of glycosyltransferases responsible for biosynthesizing N-acetyllactosamine by the transfer of a galactose from UDP-galactose to the terminal N-acetylgluosamine of acceptor sugars in glycoproteins or glycolipids with a beta-1,4-linkage
-
-
?
additional information
?
-
complex penta-antennary N-glycan structure, detailed substrate binding structure analysis of the wild-type and mutant M340H enzymes, overview
-
-
?
additional information
?
-
-
substrate specificity of wild-type and mutant Y289L enzymes, overview
-
-
?
additional information
?
-
-
beta 1,4GalT V galactosylates the beta1,6-GlcNAc branch of N-glycans at the cell surface and of secreted glycoproteins, and functions as a positive regulator in glioma development, overview. As2O3-induced gioma cell apoptosis mechanism involves beta 1,4GalT V inhibition, overview
-
-
?
additional information
?
-
-
beta-1,4-galactosylransferase participates in the synthesis of Galbeta1-4-GlcNac disaccharide unit of glycoconjugates, overview
-
-
?
additional information
?
-
-
the specific inhibitors of the phosphatidylinositol 3-kinase LY294002 and wortmannin up-regulate beta1,4-galactosyltransferase I and thus sensitize SMMC-7721 human hepatocarcinoma cells to cycloheximide-induced apoptosis, overview
-
-
?
additional information
?
-
-
beta4Gal-T1 participates in the synthesis of Galbeta1-4-GlcNac disaccharide unit of glycoconjugates
-
-
?
additional information
?
-
-
UDP-mannose and UDP-N-acetyl galactosamine are no substrates for soluble beta1,4-GalT7
-
-
?
additional information
?
-
-
LgtB is the beta-1,4-galactosyltransferase involved in the biosynthesis of the lipopolysaccharide O-chain backbone of Helicobacter pylori
-
-
?
additional information
?
-
-
no activity with GlcNAc6Sbeta(1->3)Lacbeta-MU, GlcNAc6NH2beta(1->3)Lacbeta-MU, GlcNH2beta(1->3)Lacbeta-MU, GalNAcbeta(1->3)Lacbeta-MU or Galbeta(1->)3Lacbeta-MU as acceptor
-
-
-
additional information
?
-
-
the enzyme is involved in regulation of carbohydrate composition of milk during lactation, endocrine enzyme regulation, overview
-
-
?
additional information
?
-
-
beta-1,4-GalT I is a type II membrane-bound glycoprotein, which occurs the plasma membrane of different types of cells where it serves as a cell surface adhesion molecule mediating various cell-cell and cell-matrix interactions such as sperm-egg binding, cell spreading, migration, and neurite outgrowth
-
-
?
additional information
?
-
beta-1,4-GalT I is a type II membrane-bound glycoprotein, which occurs the plasma membrane of different types of cells where it serves as a cell surface adhesion molecule mediating various cell-cell and cell-matrix interactions such as sperm-egg binding, cell spreading, migration, and neurite outgrowth
-
-
?
additional information
?
-
-
beta-1,4-GalT-I plays a key role in the synthesis of selectin ligands such as sialy Lewis, sLex, and sulfated sLex, overview. beta-1,4-GalT-I may play an important role in the inflammation reaction
-
-
?
additional information
?
-
-
beta-1,4-GalT-I transfers galactose from UDP-galactose donors to terminal N-acetylglucosamine of carbohydrate chains in beta-1,4-linkage to form a Galbeta1->4GlcNAc structure
-
-
?
